Building the Largest Database of Human Microbiomes

On Demand

1 hr 4 min

Share webinar

Launched in 2019, the Million Microbiome of Humans Project, a collaboration among scientists from 21 institutions across 10+ countries, aims to analyze 1 million microbial samples from various human organs within 3-5 years, using metagenomic sequencing to create the largest global human microbiome database.

Making the implementation of monogenic hereditary diseases diagnosis easy  Speaker details but you dont need to include this in the description Dr. Paula Sancho Salmerón, PhD, Product Manager GeneSystems @Sistemas Genómicos
Making the implementation of monogenic hereditary diseases diagnosis easy  Speaker details but you dont need to include this in the description Dr. Paula Sancho Salmerón, PhD, Product Manager GeneSystems @Sistemas Genómicos
Making the implementation of monogenic hereditary diseases diagnosis easy  Speaker details but you dont need to include this in the description Dr. Paula Sancho Salmerón, PhD, Product Manager GeneSystems @Sistemas Genómicos

Making The Implementation of Monogenic Hereditary Diseases Diagnosis Easy

Making The Implementation of Monogenic Hereditary Diseases Diagnosis Easy

Making The Implementation of Monogenic Hereditary Diseases Diagnosis Easy

Comprehensive Molecular Tumour Analysis (CMTA) integrates RNA-seq and the Tumour Microenvironment (TME) for targeted therapy Speaker, Dr. Marie-laure Yaspo
Comprehensive Molecular Tumour Analysis (CMTA) integrates RNA-seq and the Tumour Microenvironment (TME) for targeted therapy Speaker, Dr. Marie-laure Yaspo
Comprehensive Molecular Tumour Analysis (CMTA) integrates RNA-seq and the Tumour Microenvironment (TME) for targeted therapy Speaker, Dr. Marie-laure Yaspo

Comprehensive Molecular Tumour Analysis (CMTA) integrates RNA-seq and the Tumour Microenvironment (TME) for targeted therapy

Comprehensive Molecular Tumour Analysis (CMTA) integrates RNA-seq and the Tumour Microenvironment (TME) for targeted therapy

Comprehensive Molecular Tumour Analysis (CMTA) integrates RNA-seq and the Tumour Microenvironment (TME) for targeted therapy

Population-based surveillance for inherited disorders Speaker, Dr. Davide Cacchiarelli
Population-based surveillance for inherited disorders Speaker, Dr. Davide Cacchiarelli
Population-based surveillance for inherited disorders Speaker, Dr. Davide Cacchiarelli

Population-based surveillance for inherited disorders

Population-based surveillance for inherited disorders

Population-based surveillance for inherited disorders

The Advantage Of Using DNBSEQ Technology​ | ESHG 2024, Speaker, Dr. Samantha Mendonsa
The Advantage Of Using DNBSEQ Technology​ | ESHG 2024, Speaker, Dr. Samantha Mendonsa
The Advantage Of Using DNBSEQ Technology​ | ESHG 2024, Speaker, Dr. Samantha Mendonsa

The Advantage Of Using DNBSEQ Technology​

The Advantage Of Using DNBSEQ Technology​

The Advantage Of Using DNBSEQ Technology​

Transforming Clinical Diagnostics, DNBSEQ-T7: Your gateway to Whole Genome Sequencing
Transforming Clinical Diagnostics, DNBSEQ-T7: Your gateway to Whole Genome Sequencing
Transforming Clinical Diagnostics, DNBSEQ-T7: Your gateway to Whole Genome Sequencing

Transforming Clinical Diagnostics

Transforming Clinical Diagnostics

Transforming Clinical Diagnostics

Closing the Cancer Care Gap with the Power of Precision Oncology
Closing the Cancer Care Gap with the Power of Precision Oncology
Closing the Cancer Care Gap with the Power of Precision Oncology

Closing the Cancer Care Gap with the Power of Precision Oncology

Closing the Cancer Care Gap with the Power of Precision Oncology

Closing the Cancer Care Gap with the Power of Precision Oncology

OncoPanels with DNBSEQ
OncoPanels with DNBSEQ
OncoPanels with DNBSEQ

OncoPanels with DNBSEQ

OncoPanels with DNBSEQ

OncoPanels with DNBSEQ

Immune Repertoire Profiling with DNBSEQ
Immune Repertoire Profiling with DNBSEQ
Immune Repertoire Profiling with DNBSEQ

Immune Repertoire Profiling with DNBSEQ

Immune Repertoire Profiling with DNBSEQ

Immune Repertoire Profiling with DNBSEQ

Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and TME for targeted therapy
Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and TME for targeted therapy
Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and TME for targeted therapy

Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and TME for targeted therapy

Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and TME for targeted therapy

Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and TME for targeted therapy

SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics

SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics

SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics

Harnessing The Power of Genomics
Harnessing The Power of Genomics
Harnessing The Power of Genomics

Revolutionizing Agriculture, Harnessing The Power of Genomics

Revolutionizing Agriculture, Harnessing The Power of Genomics

Revolutionizing Agriculture, Harnessing The Power of Genomics

Whole Exome Sequencing with DNBSEQ
Whole Exome Sequencing with DNBSEQ
Whole Exome Sequencing with DNBSEQ

Whole Exome Sequencing with DNBSEQ

Whole Exome Sequencing with DNBSEQ

Whole Exome Sequencing with DNBSEQ

Clinical Exome Sequencing to reporting
Clinical Exome Sequencing to reporting
Clinical Exome Sequencing to reporting

Clinical Exome Sequencing to reporting

Clinical Exome Sequencing to reporting

Clinical Exome Sequencing to reporting

pagination here
pagination here
Genomics Unlocked Background

Join our newsletter to stay up to date on our latest webinars.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Genomics Unlocked Background

Join our newsletter to stay up to date on our latest webinars.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Genomics Unlocked Background

Join our newsletter to stay up to date on our latest webinars.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.